<DOC>
	<DOCNO>NCT02338141</DOCNO>
	<brief_summary>This study evaluate effectiveness portable colposcopy compare conventional colposcopy ( 25x magnification cervix , gold standard ) Visualization Inspection Acetic acid ( VIA , 1x magnification , accept low-resource method ) . Half participant evaluate cervical pathology portable colposcopy VIA assessment , half evaluate conventional colposcopy . This study also use collect lab specimens human papillomavirus ( HPV ) -positive woman determine HPV genotype prevalent among high grade disease case ( CIN II+ ) among sub-group human immunodeficiency virus ( HIV ) -positive woman .</brief_summary>
	<brief_title>Accuracy Portable Colposcopy HPV Genotypes Among HIV+ Women</brief_title>
	<detailed_description>This research randomize , prospective trial design evaluate value magnification make diagnosis high grade intraepithelial lesion cervix . The overall goal evaluate cervical cancer screen protocol provide high level care possible low-resource community hard-to-reach area . Currently , national cervical cancer screen diagnosis program exist within Haiti . All woman meet inclusion criterion randomize portable ( 8x magnification Cerviscope ) conventional ( 25x magnification ) colposcopy . After application acetic acid cervix , physician record naked eye observation cervix : 1 ) record location white lesion ; 2 ) describe vascular pattern ; 3 ) state his/her clinical impression diagnosis . The physician follow-up use either portable conventional colposcope : 1 ) record location white lesion ; 2 ) describe vascular pattern ; 3 ) state clinical impression diagnosis . Women biopsies four quadrant cervix even cervical lesion see evaluate accuracy visualization technique gold standard biopsy pathologic result . Treatment option dictate biopsy result . Biopsy material also evaluate specific HPV genotype use lab-based measure . Results genotype compare woman high-grade disease vs. low-grade disease subset woman HIV compare HIV-negative population .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Retinol acetate</mesh_term>
	<criteria>Female 2560 year old Pretested positive human papillomavirus ( HPV ) Pretested negative human papillomavirus ( HPV ) Pregnant time enrollment Prior hysterectomy &lt; 25 &gt; 60 year old Male</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>cervical cancer</keyword>
	<keyword>colposcopy</keyword>
	<keyword>human papillomavirus</keyword>
	<keyword>human immunodeficiency virus</keyword>
</DOC>